Meanwhile, adjuvanted multi-antigen TB vaccine development can target induction of multi-antigen and multi-faceted immune responses, triggering IgM, IgG, lung resident TRMs and IFNγ independent immune responses with the goal of overcoming TB’s active impairment of host immunity that otherwise restricts immunity and prevents sterilizing immunity. Here, IFNG is linked to tuberculosis.